Last Updated:
August 11,2014Original Published:
August 11,2014There are no early stage diagnostics for ovarian cancer and by the time they are discovered, they may not respond to standard cancer treatments. But a new research from A*STAR's Institute of Medical Biology (IMB) and the Bioinformatics Institute (BII) have found new clues to early detection and personalized treatments of ovarian cancer, thus offering hope to millions of women who might be susceptible to it.